News December 23, 2015 OrbiMed Launches $950 Million Venture Capital Fund – Business Wire OrbiMed, a leading investment firm focused on the healthcare sector, announced the closing of its… Super User 0 Love0
BHI Client News December 23, 2015 Mimetas and Partners Receive 1.6 Million Dollar Industry Funding for Development of Organ-On-A-Chip Neurotoxicity Models Leiden-based biotechnology company Mimetas has received 1.6 million USD funding for development of an organ-on-a-chip… Super User 0 Love0
News December 23, 2015 GSK had the biggest global health breakthrough of 2015 – Fortune It’s taken 30 years and more than $565 million to make it happen: the first-ever… Super User 0 Love0
News December 21, 2015 Alexandria Real Estate Equities: What Does It Do? – Market Realist Headquartered in Pasadena, California, Alexandria Real Estate Equities (ARE) was founded by Joel S. Marcus… Super User 0 Love0
News December 21, 2015 Medigene AG announces key Management Changes – NASDAQ.com Chief Scientific Officer Prof Dolores Schendel appointed new Chief Executive Officer of Medigene AG Dave… Super User 0 Love0
News December 21, 2015 Eye cells grown at Johns Hopkins may lead to a cure for some forms of blindness – Baltimore Sun Drs. Donald Zack and Valentin Sluch spent 30 anxious days waiting for their experiment to… Super User 0 Love0
News December 21, 2015 PE HUBBrace Pharma Capital leads $33 mln Series B funding in Navitor – PE HUB Brace Pharma Capital led a $33 million Series B funding in Navitor Pharmaceuticals, a biopharmaceutical… Super User 0 Love0
News December 21, 2015 2016 Health Datapalooza VII Announces Nominations for Health Data Liberators Award Now Accepted May 8 - 11, 2016 ANNOUNCING NOMINATIONS NEW BEING ACCEPTED FOR THE HEALTH DATA LIBERATORS… Super User 0 Love0
News December 21, 2015 Baltimore health IT firm DinnerTime lands contract with Evergreen Health Co-op – Baltimore Business Journal It’s hard to get people to eat right. Healthy food can be expensive and time… Super User 0 Love0
News December 21, 2015 GSK to buy HIV drugs from Bristol-Myers Squibb for initial $350 million – Reuters Pharmaceutical group GlaxoSmithKline said its majority-owned HIV business would buy drugs at different stages of… Super User 0 Love0